[
  {
    "ts": "2025-06-27T19:28:00+00:00",
    "headline": "RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening",
    "summary": "Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and EchocardiogramsAPOLLO BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurposed drug development for early detection and treatment of eye and systemic diseases, has entered into an agr",
    "url": "https://finance.yahoo.com/news/retinalgenix-technologies-contracts-labcorp-support-192800673.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "4b653f0e-590a-369f-9332-9af9951c4edd",
      "content": {
        "id": "4b653f0e-590a-369f-9332-9af9951c4edd",
        "contentType": "STORY",
        "title": "RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening",
        "description": "",
        "summary": "Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and EchocardiogramsAPOLLO BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurposed drug development for early detection and treatment of eye and systemic diseases, has entered into an agr",
        "pubDate": "2025-06-27T19:28:00Z",
        "displayTime": "2025-06-27T19:28:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/88cc5f24a090bac40ee1074cdcaeef36",
          "originalWidth": 1562,
          "originalHeight": 724,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xYuAracClZBZqgkU39WLZA--~B/aD03MjQ7dz0xNTYyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/88cc5f24a090bac40ee1074cdcaeef36.cf.webp",
              "width": 1562,
              "height": 724,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7AVcD0r4QXkntD1XUdmT_A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/88cc5f24a090bac40ee1074cdcaeef36.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/retinalgenix-technologies-contracts-labcorp-support-192800673.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/retinalgenix-technologies-contracts-labcorp-support-192800673.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LH"
            },
            {
              "symbol": "RTGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]